These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20618839)

  • 21. Neuromyelitis optica with clinical and histopathological involvement of the brain.
    Hengstman GJ; Wesseling P; Frenken CW; Jongen PJ
    Mult Scler; 2007 Jun; 13(5):679-82. PubMed ID: 17548452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The astrocyte in multiple sclerosis revisited.
    Brosnan CF; Raine CS
    Glia; 2013 Apr; 61(4):453-65. PubMed ID: 23322421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Other demyelinating diseases.
    Tselis AC; Lisak RP
    Adv Neurol; 2006; 98():335-49. PubMed ID: 16400843
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuromyelitis optica--report of an autopsy proven case from South India.
    Shankar SK; Gourie-Devi M; Nagaraja D; Rao TV; Das S
    J Assoc Physicians India; 1984 Apr; 32(4):371-3. PubMed ID: 6746554
    [No Abstract]   [Full Text] [Related]  

  • 25. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute paraplegia with vanishing white matter lesions.
    Jensen RM; Kinkel RP
    Rev Neurol Dis; 2008; 5(3):159-60; discussion 164-6. PubMed ID: 18838956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders.
    Cabrera-Gómez J; Saiz-Hinarejos A; Graus F; González-Quevedo A; Rodríguez-Rojas R; Quevedo-Sotolongo L; Real-González Y; Grass-Fernández D; Cristófol-Corominas M; Rodríguez-Cordero M; Robinson-Agramonte M; Infante-Velázquez E; Cabrera-Núñez A; Ugarte-Sánchez C; Jordán-González J; González de la Nuez J; García-Lahera J; Tellez R; Baez-Martín M; Romero-García K
    Mult Scler; 2008 Mar; 14(2):248-51. PubMed ID: 18208893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [MRI and CSF features in neuromyelitis optica].
    Misu T
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():277-82. PubMed ID: 26480713
    [No Abstract]   [Full Text] [Related]  

  • 29. A case of neuromyelitis optica (Devic's disease).
    Banerjee A; Bishop A; Elliott P
    Practitioner; 1989 Feb; 233(1463):202, 205. PubMed ID: 2587480
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anatomopathological lesions of the optic pathways and of the brain stem in multiple sclerosis].
    Perier O
    Bull Soc Belge Ophtalmol; 1982; 199-200():83-94. PubMed ID: 6189541
    [No Abstract]   [Full Text] [Related]  

  • 31. Brain abnormalities in neuromyelitis optica.
    Pittock SJ; Lennon VA; Krecke K; Wingerchuk DM; Lucchinetti CF; Weinshenker BG
    Arch Neurol; 2006 Mar; 63(3):390-6. PubMed ID: 16533966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comment on severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.
    Arrambide G; Tur C; Montalban X
    Mult Scler; 2015 Apr; 21(5):660-1. PubMed ID: 25662350
    [No Abstract]   [Full Text] [Related]  

  • 33. Complexity and heterogeneity in demyelinating disease.
    Compston A
    Brain; 2007 May; 130(Pt 5):1178-80. PubMed ID: 17472981
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.
    Bradl M; Misu T; Takahashi T; Watanabe M; Mader S; Reindl M; Adzemovic M; Bauer J; Berger T; Fujihara K; Itoyama Y; Lassmann H
    Ann Neurol; 2009 Nov; 66(5):630-43. PubMed ID: 19937948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intractable vomiting as the initial presentation of neuromyelitis optica.
    Apiwattanakul M; Popescu BF; Matiello M; Weinshenker BG; Lucchinetti CF; Lennon VA; McKeon A; Carpenter AF; Miller GM; Pittock SJ
    Ann Neurol; 2010 Nov; 68(5):757-61. PubMed ID: 21031587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromyelitis optica in a patient with an early onset demyelinating episode: clinical and autoantibody findings.
    Beyer AM; Wandinger KP; Siebert E; Zschenderlein R; Klehmet J
    Clin Neurol Neurosurg; 2007 Dec; 109(10):926-30. PubMed ID: 17913344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
    Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset.
    Nishiyama S; Ito T; Misu T; Takahashi T; Kikuchi A; Suzuki N; Jin K; Aoki M; Fujihara K; Itoyama Y
    Neurology; 2009 Jun; 72(22):1960-1. PubMed ID: 19487655
    [No Abstract]   [Full Text] [Related]  

  • 39. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current concepts in the diagnosis of transverse myelopathies.
    Brinar VV; Habek M; Zadro I; Barun B; Ozretić D; Vranjes D
    Clin Neurol Neurosurg; 2008 Nov; 110(9):919-27. PubMed ID: 18718707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.